Deenova's Transition to Equiter Infrastructure Marks a Strategic Partnership
Deal News | Nov 21, 2024 | Finance Community IT - 3 Private Equity

H.I.G. Capital has finalized an agreement to sell Deenova, a prominent Italian provider of advanced automation and traceability services for hospital medications and medical devices, to Equiter Infrastructure II. This acquisition is supported by Ersel Asset Management SGR, Amundi Private Equity Italia, and Deenova's founder, Sergio Giglio. Deenova, operational since 2004, integrates cutting-edge systems in hospitals across Europe, enhancing patient safety, reducing costs, and optimizing processes. Advisors for the transaction included William Blair as financial advisor for Deenova, with Eversheds Sutherland providing legal counsel, and EY conducting financial due diligence. Meanwhile, Deloitte advised Equiter Infrastructure financially and fiscally, with White & Case serving as legal counsel. Over the years, Deenova expanded its European presence under H.I.G.'s backing and is now poised for further growth with its new partners.
Sectors
- Healthcare Technology
- Private Equity
- Financial Advisory
Geography
- Italy – Deenova is an Italian company, and several firms involved in the transaction, including advisors, are based or operate in Italy.
- Europe – Deenova has a significant presence in European countries, and the private equity firms involved operate internationally, highlighting a wider European focus.
Industry
- Healthcare Technology – Deenova operates within the healthcare technology sector by providing automation and traceability solutions for medications and medical devices in hospitals.
- Private Equity – The transaction involves multiple private equity firms, including H.I.G. Capital, Equiter Infrastructure, and Amundi Private Equity Italia.
- Financial Advisory – Advisory firms played a critical role in the transaction, providing financial, legal, and due diligence services.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Deenova | Target company | Company | An Italian company providing automation and traceability services for medications and medical devices in hospitals. |
| H.I.G. Capital | Selling company | Company | An international private equity investment firm that sold its portfolio company Deenova. |
| Equiter Infrastructure II | Bidding company | Company | The fund acquiring Deenova, managed by Ersel Asset Management SGR. |
| Amundi Private Equity Italia | Minority investor | Company | A private equity firm partnering in the acquisition with a minority stake. |
| Sergio Giglio | Partner | Person | Founder of Deenova and a partner in the acquisition deal. |
| William Blair | Financial advisor | Company | Provided financial advisory services to Deenova in the transaction. |
| Eversheds Sutherland | Legal advisor | Company | Served as legal advisor for Deenova during the deal. |
| EY | Financial due diligence | Company | Conducted financial due diligence for the Deenova transaction. |
| Deloitte | Financial and tax advisor | Company | Advised Equiter Infrastructure in financial and fiscal matters. |
| White & Case | Legal advisor | Company | Provided legal advisory services to Equiter Infrastructure. |
| Crea Avvocati Associati | Legal advisor | Company | Assisted Sergio Giglio with legal matters in the transaction. |